Racial/ethnic minorities are disproportionately affected by type 2 diabetes and its associated complications. Research shows that racial/ethnic minorities present with more advance disease, are less likely to achieve glycemic control, and are more likely to experience adverse outcomes such as amputation and nephropathy. Findings from prevention and intervention studies demonstrate the effectiveness of early intervention methods, including lifestyle modifications and medication, in delaying or preventing at-risk individuals from progressing to overt disease. The early identification of at-risk individuals is therefore essential to reduce diabetes burden in racial/ethnic and other populations. Few methods currently exist for the early identification of individuals at increased risk for the development of diabetes. The proposed study aims to identify novel methods of identification through the integration of genetic and behavioral markers of diabetes risk in the Eastern Caribbean Health Outcomes Research Network Cohort, an existing community-dwelling cohort in Region II. The development and testing of novel identification methods, using integrated data, advances efforts to apply precision medicine to improve population health and reduce racial/ethnic disparities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD010711-05
Application #
9972762
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520